Myasthenia gravis (MG) is an autoimmune neurological disorder characterized by defective
transmission at the neuromuscular junction. The incidence of the disease is 4.1 to 30 cases …

Myasthenia gravis (MG) is an autoimmune neuromuscular disorder which is characterized
by presence of antibodies against acetylcholine receptors (AChRs) or other proteins of the …

Granulocyte-macrophage colony-stimulating factor (GM-CSF) was first described as a
growth factor that induces the differentiation and proliferation of myeloid progenitors in the …

Myasthenia gravis (MG) is characterized by muscle weakness and fatigue caused by the
presence of autoantibodies against the acetylcholine receptor (AChR) or the muscle-specific …

Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction (NMJ).
Autoantibodies target key molecules at the NMJ, such as the nicotinic acetylcholine receptor …

Myasthenia gravis (MG) is an archetypal autoimmune disease. The pathology is
characterized by autoantibodies to the acetylcholine receptor (AChR) in most patients or to …

B cells have an ever-increasing role in the etiopathology of a number of autoimmune
neurological disorders, acting as antigen-presenting cells facilitating antibody production but …

Autoimmune diseases (ADs) showcase the intricate balance between the immune system's
protective functions and its potential for self-inflicted damage. These disorders arise from the …

While inflammation may not be the cause of disease, it is well known that it contributes to
disease pathogenesis across a multitude of peripheral and central nervous system …

Myasthenia gravis (MG) is an autoimmune disease characterized by impaired
neuromuscular signaling due to autoantibodies targeting the acetylcholine receptor …